Einat Galamidi - 18 Mar 2026 Form 3 Insider Report for Enlivex Ltd. (ENLV)

Signature
/s/ Shachar Shlosberger, Attorney-in-Fact
Issuer symbol
ENLV
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 07:01:30 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galamidi Einat Chief Medical Officer 14 EINSTEIN STREET, NESS ZIONA, ISRAEL /s/ Shachar Shlosberger, Attorney-in-Fact 18 Mar 2026 0002076463

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENLV Ordinary Shares, par value NIS 0.40 per share 156,304 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENLV Employee Stock Option (right to buy) 18 Mar 2026 Ordinary Shares, par value NIS 0.40 per share 25,000 $5.34 Direct
holding ENLV Employee Stock Option (right to buy) 18 Mar 2026 Ordinary Shares, par value NIS 0.40 per share 10,000 $3.21 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

See Exhibit 24.1 - Power of Attorney